N4 Pharma Plc (N4P.L) Stock Price
£0.375 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
7 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on N4 Pharma Plc, AI stock picks, stock alerts and much more.
N4P.L AI Stock Analysis
AI stock analysis for N4P.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like N4 Pharma Plc (N4P.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
N4 Pharma Plc (N4P.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of N4 Pharma Plc (N4P.L), currently trading at £0.375, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About N4P.L
-
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom.
-
Symbol
N4P.L
-
Market
LSE
-
Industry
Drug Manufacturers - Specialty & Generic
-
Market Cap
3.1M
Similar Stocks
 |
Shield Therapeutics STX.L |
£2.85 3.2% |
3 |
 |
Indivior PLC INDV.L |
£1145 2.1% |
4 |
 |
Haleon plc HLN.L |
£371.3 1.8% |
6 |
 |
HUTCHMED (China) Limited HCM.L |
£226 1.3% |
4 |
 |
Hikma Pharmaceuticals PLC HIK.L |
£1981 0.1% |
6 |
News
N4P.L Alternative Data
Web Traffic
N4 Pharma Plc receives an estimated 1222 monthly visitors to n4pharma.com.
-
Web Traffic
1222
-
Change from Previous Month
0.3%
-
3 Month Change
80.2%
-
YoY Change
80.2%
Twitter Followers
N4 Pharma Plc has 923 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.4% over the last month.
-
Twitter Followers
923
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
0%
LinkedIn Followers
591 are following N4 Pharma Plc on LinkedIn, up by 2.8% over the last month.
-
LinkedIn Followers
591
-
Daily Change
2.8%
-
1 Month Change
2.8%
-
3 Month Change
6.5%
LinkedIn Employees
According to LinkedIn, N4 Pharma Plc has 4 employees.
-
LinkedIn Employees
4
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
News Mentions
N4 Pharma Plc was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
N4 Pharma Plc has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
-
3 Month Change
0%
N4P.L Financials
N4P.L Key Metrics
-
Total Revenue
£3.9K
-
Net Income
-£454.9K
-
Earnings per Share
-£0.0016
-
Free cash flow
-£390.9K
-
EBITDA
-£491.7K
-
EBITDA Ratio
-125.885
-
Total Assets
£1.3M
N4P.L 2-year Revenue & Income
N4P.L 2-year Free Cash Flow
N4P.L Technicals
N4P.L SMA
N4P.L RSI
FAQ
What's the current price of N4 Pharma Plc (N4P.L) Stock?
The price of an N4 Pharma Plc (N4P.L) share is £0.375.
What's the market cap of N4 Pharma Plc?
The current market cap of N4 Pharma Plc is 3.1M.
Should I buy or sell N4P.L?
N4 Pharma Plc shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, N4 Pharma Plc is better viewed as a hold or accumulate position while waiting for further developments.
Is N4 Pharma Plc a good investment?
The current analysis of N4 Pharma Plc's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in N4 Pharma Plc's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy N4 Pharma Plc (N4P.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for N4 Pharma Plc stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to N4 Pharma Plc (N4P.L) that investors often compare it to?
N4 Pharma Plc (N4P.L) is often compared to similar stocks such as Shield Therapeutics, Indivior PLC, Haleon plc, HUTCHMED (China) Limited and Hikma Pharmaceuticals PLC.
What is the forecast for N4 Pharma Plc's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast N4 Pharma Plc's stock price to be around £0.386 in 2026. Starting from the current price of £0.375, this represents a 2.9% change in price, indicating a neutral outlook for the stock.
How to buy N4 Pharma Plc (N4P.L) Stock?
N4 Pharma Plc stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy N4 Pharma Plc shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.